Allergan (AGN) – Insiders' Blog
-
Complete Donald Trump Stock Impact Guide
-
Investors Brace for Historic U.S. Election
-
Biotech Investors Look for Next Jackpot After Tobira (TBRA) Acquired at up to a 1650% Premium
-
Carl Icahn Calls Pfizer/Allergan Deal a 'Travesty' - NY Times Op-Ed
-
Pfizer-Allergan talks accelerate amid new inversion clamp-down
-
How Pfizer has shifted U.S. profits overseas for years
-
Top 10 S&P 500 Performers of 2014
-
Bill Ackman Preparing New 'Decent-Sized' Stake, Talks IPO, Allgergan (AGN), Herbalife (HLF) and Fannie/Freddie (FNMA) (FMCC)
-
Allergan (AGN) Files to Block Ackman's Pershing Square from Voting at Dec. Meeting (VRX)
-
S&P 500 Reaches 2,000 Milestone for First Time Ever
-
Ackman, Icahn Discuss Reconciling Differences at Delivering Alpha
-
Allergan (AGN) CEO Pyott: We're Looking to Do Our Own Acquisitions (VRX) (SHPG)
-
Pershing Square Taps Top Global Bank in Effort to Bring Valeant (VRX) and Allergan (AGN) Together
-
Recnt Dip in Allergan (AGN) Shares Might Have Bidders Lining Up (GSK) (MRK)
-
Allergan (AGN) Slips Lower on FDA Generic Restasis Discussion
-
Recent Dip May Provide Long-Term Opportunity on Allergan (AGN) - Cramer
-
Allergan (AGN) Ticks Higher; CEO Pyott Speaks on CNBC
-
Allergan (AGN) Dips as FDA Approves Sientra Silimed-Brand Implants
-
Allergan (AGN) Moves Higher on New Botox Indication
-
Debt Deals Flood Market
-
Traders Cheer Allergan's (AGN) Q2 Results as Profit Surges 36%
-
Wall Street Hubbub 7/14: iPhone 4 Recall, Penthouse-for-Playboy, BP's New Cap Is No Savior, KKR IPO, Treasury Weighs Citi (C) Options
-
Genzyme (GENZ) Creeps Higher On Potential Biotech Mega-Deal
-
Loeb's Third Point Q4 13F Breakdown: Ups Bets In Financials, Exits Large Pharma
-
Sanofi-Aventis (SNY) On the Prowl For A Mega-Deal In the U.S.?
-
Cramer Says Pfizer (PFE) Should Buy Allergan (AGN)
-
Biotech Takeover Buzz Hot and Heavy After ImClone Offer (ONXX, OSIP, BIIB, AMLN, XPNT, CYPB, ISPH)
-
Potential Bounce Candidates: ARUN, PDFS, SCOR, AGN, BW
-
Fidelity Magellan Fund To Re-Open To New Investors
-
MRK Looking At Acquisitions to Boost Their Drug Business
Back to AGN Stock Lookup